Retrospective Study on the Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes in Northern Taiwan

References

• Zhu N, Zhang D, Wang W, et al. China novel coronavirus investigating and research team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Fauci AS, Lane HC, Redfield RR. Covid-19 - navigating the uncharted. N Engl J Med. 2020;382:1268–1269. doi:10.1056/NEJMe2002387
   PubMed Web of Science ®Google Scholar
• Han E, Chiou ST, McKee M, Legido-Quigley H. The resilience of Taiwan’s health system to address the COVID-19 pandemic. EClinicalMedicine. 2020;24:100437. doi:10.1016/j.eclinm.2020.100437
   PubMedGoogle Scholar
• Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. JAMA. 2020;323:1341–1342. doi:10.1001/jama.2020.3151
   PubMed Web of Science ®Google Scholar
• Lee WC, Su SY. Epidemic trend of COVID-19 in Taiwan, May to June 2021. J Formos Med Assoc. 2022;121:580–581. doi:10.1016/j.jfma.2021.08.022
   PubMed Web of Science ®Google Scholar
• Carpenter R, DiChiacchio T, Barker K. Interventions for self-management of type 2 diabetes: an integrative review. Int J Nurs Sci. 2018;6:70–91. doi:10.1016/j.ijnss.2018.12.002
   PubMed Web of Science ®Google Scholar
• Ojo O, Wang XH, Ojo OO, et al. The Effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:1095. doi:10.3390/ijerph19031095
   PubMed Web of Science ®Google Scholar
• Han Y, Chen Y, Sun C, Zhou Z. The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: a systematic review and meta-analysis of 22 observational studies. Front Endocrinol. 2022;13:1069559. doi:10.3389/fendo.2022.1069559
   PubMed Web of Science ®Google Scholar
• Wafa IA, Pratama NR, Sofia NF, et al. Impact of COVID-19 lockdown on the metabolic control parameters in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2022;46:260–272. doi:10.4093/dmj.2021.0125
   PubMed Web of Science ®Google Scholar
• O’Mahoney LL, Highton PJ, Kudlek L, et al. The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2022;24:1850–1860. doi:10.1111/dom.14771
   PubMed Web of Science ®Google Scholar
• D’Onofrio L, Pieralice S, Maddaloni E, et al. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study. Diabetes Obes Metab. 2021;23:1624–1630. doi:10.1111/dom.14380
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Recommendations on Physical Activity for Health. Geneva: World Health Organization; 2010.
   Google Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al.; on behalf of the American Diabetes Association. Glycemic targets: standards of care in diabetes-2023. Diabetes Care. 46;2023:S97–110. doi:10.2337/dc23-S006
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254. doi:10.7326/0003-4819-145-4-200608150-00004
   PubMed Web of Science ®Google Scholar
• Lashkarbolouk N, Mazandarani M, Pourghazi F, et al. How did lockdown and social distancing policies change the eating habits of diabetic patients during the COVID-19 pandemic? A systematic review. Front Psychol. 2022;13:1002665. doi:10.3389/fpsyg.2022.1002665
   PubMed Web of Science ®Google Scholar
• Lin CL, Huang LC, Chang YT, Chen RY, Yang SH. Under COVID-19 pandemic: a quasi-experimental trial of observation on diabetes patients’ health behavior affected by the pandemic from a coaching intervention program. Front Public Health. 2021;9:580032. doi:10.3389/fpubh.2021.580032
   PubMed Web of Science ®Google Scholar
• Park SD, Kim SW, Moon JS, et al. Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus. Diabetes Metab J. 2021;45:109–114. doi:10.4093/dmj.2020.0226
   PubMed Web of Science ®Google Scholar
• Biamonte E, Pegoraro F, Carrone F, et al. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine. 2021;72:604–610. doi:10.1007/s12020-021-02739-5
   PubMed Web of Science ®Google Scholar
• Munekawa C, Hosomi Y, Hashimoto Y, et al. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study. Endocr J. 2021;68:201–210. doi:10.1507/endocrj.EJ20-0426
   PubMed Web of Science ®Google Scholar
• Ludwig L, Scheyer N, Remen T, Guerci B. The impact of COVID-19 lockdown on metabolic control and access to healthcare in people with diabetes: the CONFI-DIAB cross-sectional study. Diabetes Ther. 2021;12:2207–2221. doi:10.1007/s13300-021-01105-y
   PubMed Web of Science ®Google Scholar
• Alyahya MS, Okour NS, Khader Y, Al-Sheyab N. Retrospective study on the impact of COVID-19 lockdown on patients with type 2 diabetes in Northern Jordan. BMJ Open. 2022;12:e065148. doi:10.1136/bmjopen-2022-065148
   PubMedGoogle Scholar
• Mohseni M, Ahmadi S, Azami-Aghdash S, et al. Challenges of routine diabetes care during COVID-19 era: a systematic search and narrative review. Prim Care Diabetes. 2021;15:918–922. doi:10.1016/j.pcd.2021.07.017
   PubMed Web of Science ®Google Scholar
• Amsah N, Md Isa Z, Ahmad N, Abdul Manaf MR. Impact of COVID-19 pandemic on healthcare utilization among patients with type 2 diabetes mellitus: a systematic review. Int J Environ Res Public Health. 2023;20:4577. doi:10.3390/ijerph20054577
   PubMedGoogle Scholar
• Cheng YC, Li YH, Liu HC, et al. The Impact of a Lockdown for the COVID-19 Pandemic on Seasonal HbA1c Variation in Patients with Type 2 Diabetes. Life. 2023;13:763. doi:10.3390/life13030763
   PubMedGoogle Scholar
• Ilias I, Rizzo M, Zabuliene L. Metformin: sex/gender differences in its uses and effects-narrative review. Medicina. 2022;58:430. doi:10.3390/medicina58030430
   PubMedGoogle Scholar
• Arnetz L, Ekberg NR, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes. 2014;7:409–420. doi:10.2147/DMSO.S51301
   PubMedGoogle Scholar
• Schütt M, Zimmermann A, Hood R, et al. DPV initiative; German BMBF competence network diabetes mellitus. gender-specific effects of treatment with lifestyle, metformin or sulfonylurea on glycemic control and body weight: a German multicenter analysis on 9 108 patients. Exp Clin Endocrinol Diabetes. 2015;123:622–626. doi:10.1055/s-0035-1559608
   PubMed Web of Science ®Google Scholar